Both in Pharmaceuticals
CorMedix vs Altimmune
Over the past year CRMD returned −53.3% and ALT returned −49.0%; their daily moves had a correlation of 0.23.
CRMD −53.3% ALT −49.0%Growth of $1, one year, split-adjusted
| Metric | CRMD | ALT |
|---|---|---|
| Price | $5.39 | $2.02 |
| Market cap | $420.1M | $392.9M |
| Today | −5.36% | −0.98% |
| 1 month | −25.0% | −26.1% |
| 6 months | −31.8% | −33.1% |
| Year to date | −53.7% | −44.0% |
| 1 year | −53.6% | −50.4% |
| Revenue growth (YoY) | +156.5% | −100.0% |
| Gross margin | 75.7% | — |
| Net margin | 25.5% | — |
| P/E (TTM) | 2.2× | — |
| Price / sales | 0.9× | 12,675.0× |
| Net cash | $256.7M | $291.5M |
| Dividend yield | — | — |
| Volatility (60d) | 77.1% | 46.8% |
| Short % of float | 20.8% | 22.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).